AIDS Prevention Policy of China. Unknown Author (2006)

AIDS Prevention Policy of China. Unknown Author (2006) Article 1. in order to prevent and control the incidence and prevalence of AIDS, to pretect human health and public health, infectious disease law, the enactment of this Ordinance.

Download this publication

Treatment Outcomes of the Modified Directly Observed Therapy (MDOT) Program of Infected Children Receiving HAART. Sophan, S (2006)

Treatment Outcomes of the Modified Directly Observed Therapy (MDOT) Program of Infected Children Receiving HAART. Sophan, S (2006) Treatment Outcomes of the Modified Directly Observed Therapy (MDOT) Program of Infected Children Receiving HAART 2006

Download this publication

The Continuum of Prevention, Care, Treatment and Support in the Build-up to Universal Access in Cambodia. Vun, MC (2006)

The Continuum of Prevention, Care, Treatment and Support in the Build-up to Universal Access in Cambodia. Vun, MC (2006) The Continuum of Prevention, Care, Treatment and Support in the Build-up to Universal Access in Cambodia

Download this publication

India: Summary Country Profile for HIV/AIDS Treatment Scale-Up. WHO (2005)

India: Summary Country Profile for HIV/AIDS Treatment Scale-Up. WHO (2005) India’s population surpassed 1 billion in 2001; 67% live in rural areas and 33% in urban areas. India is estimated to have the second largest population of people living with HIV/AIDS, next to South Africa. An estimated 5.13 million individuals currently live with HIV across all states in India. In areas that are more severely affected, the epidemic has started to challenge recent development achievements and to raise fundamental issues of human rights concerning people living with HIV/AIDS.


Download this publication

Papua New Guinea: Establishment of Pilot HIV/AIDS Care Centers. ADB (2005)

Papua New Guinea: Establishment of Pilot HIV/AIDS Care Centers. ADB (2005) ince 1987, 9851 cases have been reported as HIV positive out of a total population of 5.4 millions (June, 2004). From consensus workshop in November, 2004, an estimated number of HIV positive among 15-49 year age group was between 45,000- 75,000 cases. Among reported case, 52.0 % were male and 48.0% were female. Heterosexual (79.9%) is the predominant mode of transmission, 93.6 % is adult. The majority of HIV/AIDS cases have been found in the National Capital District (60.8 %) and Western Highland (14,3 %) province.

Download this publication

Papua New Guinea: Summary Country Profile for HIV/AIDS Treatment Scale Up. WHO (2005)

Papua New Guinea: Summary Country Profile for HIV/AIDS Treatment Scale Up. WHO (2005) The first case of HIV infection in Papua New Guinea was detected in 1987. By June 2005, 12 341 people had been reported to be living with HIV/AIDS. The country is facing a generalized epidemic with rapidly increasing prevalence in a difficult socioeconomic context. A national epidemiological consensus meeting in November 2004 estimated an average prevalence rate of 1.7%, and between 25 000 and 69 000 people with 15-49 years were living with HIV/AIDS. Prevalence rates among women attending antenatal care services are estimated to vary between 1% and 4%. Available data suggests that the epidemic is predominantly transmitted through heterosexual contact (84%), fuelled by high-risk behaviour including widespread commercial and casual sex. Approximately 93.1% of current reported cases are adults.

Download this publication

Vietnam: Summary Country Profile for HIV/AIDS Treatment Scale-Up. WHO (2005)

Vietnam: Summary Country Profile for HIV/AIDS Treatment Scale-Up. WHO (2005) Viet Nam is facing a rapidly growing HIV epidemic that is beginning to extend beyond initial concentrations in networks of injecting drug users and sex workers. The number of people living with HIV doubled between 2000 and 2005, from approximately 122 000 to 263 000. The adult HIV prevalence is estimated to be 0.5% at the national level in 2005 but exceeded 1% in several provinces. There were an estimated 37 000 new infections in 2005. Due to increased heterosexual transmission, the number of infected females compared with males is increasing each year. In 2005, the ratio was estimated to be 2 to 1, males to females. The number of AIDS-related deaths is growing and is estimated to have increased from 9000 in 2003 to 14 000 in 2005.

Download this publication

Scaling Up Anti-Retroviral Treatment to (Injecting) Drug Users in Asia. Asian Harm Reduction Network (2005)

Scaling Up Anti-Retroviral Treatment to (Injecting) Drug Users in Asia. Asian Harm Reduction Network (2005) In light of the endorsement of the AIDS Care Watch Campaign, led by Health and Development Networks (HDN), the Asian Harm Reduction Network (AHRN) believes that addressing issues related to injecting drug use (IDU) and anti-retroviral treatment (ART) is essential in the Asian context. Notably, AHRN believes that the provision of ART for IDUs is a fairly recent area which has not received due attention and deserves more research and consideration.

Download this publication

Guidelines for HIV Diagnosis and Monitoring of Antiretroviral Therapy. WHO (2005)

Guidelines for HIV Diagnosis and Monitoring of Antiretroviral Therapy. WHO (2005) The human immunodeficiency virus (HIV) has changed the social, moral, economic and health fabric of the world in a short span. Today HIV/AIDS is the greatest health crisis faced by the global community. Till date, this pandemic has killed nearly 30 million people. More than 40 million are living with HIV, and to this pool, an additional 14 000 are added everyday. It is expected that, if not treated, 3 million people will die every year of HIV/AIDS. It is estimated that of the millions of people living with HIV/AIDS (PLWHA) in developing countries, 6 million people require antiretroviral therapy (ART). Most of these are in 34 high burden countries of Africa and Asia.

Download this publication

Pages

Data Dashboard
database
Highlighted publications
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS-young-peoples-participation-in-community-based-responses-to-hiv_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNODC_factsheet_Ending_AIDS_by_2030_for_people_and_with_PUD_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_GAP_progress_report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HRI-women-harm-reduction-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Elective_C-section_should_not_be_routinely_recommended_to_WLHIV_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/ESCAP_Asia_and_the_Pacific_SDG_Progress_Report_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guideline_on_digital_interventions_for_health_system_strengthening_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Progress_report_on_HIV_viral_hepatitis_and_STI_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV_UHC_Guide_Civil_Society_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_Annual_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_HIV-related-travel-restrictions-explainer_2019.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/HIV-and-the-Law-supplement-2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_IBBS_and_Population_size_estimates_among_FSW_2015.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Global_TB_Report_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Nepal_National_Community_Led_HIV_Testing_Guidelines_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_PWID_PWUD_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_IBBS_FEW_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/DataHub_TB-HIV_Fact_Sheet_2018.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NSACP_Sri_Lanka_National_HIV_Communication_Strategy_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Status_of_National_AIDS_Response_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V1_North-East_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V2_West_South_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_State_Epi_factsheets_V3_Northern_Central_Eastern_region_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/NACO_Annual_report_2016-17.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_for_Managing_Advanced_HIV_Disease_and_Rapid_Initiation_of_ART_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Cambodia_Estimations_and_projections_of_HIV_AIDS_at_Sub-national_level_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_HIV_drug_resistance_report_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Guidelines_on_public_health_response_to_pretreatment_HIV_drug_resistance_2017.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/Myanmar_National_Strategic_Plan_on_HIV_and_AIDS_2016-2020.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/UNAIDS_methods_for_deriving_estimates_2016.pdf
https://aidsdatahub.org/sites/default/files/highlight-reference/document/WHO_Consolidated_on_the_use_of_antiretroviral_drugs_for_treating_and_preventing_HIV_infection_2016.pdf
Calendar of events
Jul
28
(28 Jul - 28 Jul)
Aug
12
(12 Aug - 12 Aug)